News | Treatment Planning | February 16, 2018

Cancer center at the University of South Alabama will also use RayStation for CyberKnife System treatment planning when the functionality is added in the future

Mitchell Cancer Institute Selects RayStation for TomoTherapy Planning

February 16, 2018 — The University of South Alabama Mitchell Cancer Institute (MCI) in Mobile, Ala., has selected RayStation as its treatment planning system for the TomoTherapy System. The center also treats patients using a CyberKnife System and will use RayStation for this in the future.

MCI’s radiation therapy service is equipped with Accuray´s CyberKnife and TomoTherapy System, as well as a 64-slice positron emission tomography/computed tomography (PET/CT) scanner. The center was initially interested in RayStation’s forthcoming support for the CyberKnife System, but saw that the system could meet all of its treatment planning needs into the future, including the TomoTherapy System.

Founded in 2000, MCI provides cancer treatment in three locations — MCI headquarters in Mobile, the MCI Kilborn Clinic in Fairhope and Monroe County Hospital in Monroeville — serving a potential catchment population of more than 4.1 million people.

Weisi Yan, M.D., Ph.D., director of the CyberKnife Program at MCI, said, “We were very impressed by the capabilities and user-friendliness of RayStation. As a leading-edge treatment center, we need the best possible technology in order to deliver outstanding care and maximize efficiency. RayStation will help us to achieve our goals.”

Hal Hopper, manager of MCI’s Department of Radiation Oncology, said, “RayStation is fast and effective in planning treatments for all possible techniques we are likely to offer. It is much less labor-intensive than other systems we have used. With RayStation, the physician can choose the best course of treatment more quickly.”

For more information: www.raysearchlabs.com

 


Related Content

News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
News | Radiology Business

July 3, 2024 — The American Society of Radiologic Technologists has launched the BeRAD Professionalism Award to ...

Time July 03, 2024
arrow
News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
News | Radiation Therapy

June 19, 2024 — RaySearch Laboratories AB announced a milestone in radiotherapy technology where RaySearch’s RayStation ...

Time June 19, 2024
arrow
News | Radiation Oncology

June 3, 2024 — The American Society for Radiation Oncology (ASTRO) published an updated clinical guideline that details ...

Time June 03, 2024
arrow
Subscribe Now